US Patent Issued to Emory University on July 21 for "VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease" (Georgia Inventors)

ALEXANDRIA, Va., July 21 -- United States Patent no. 12,685,761, issued on July 21, was assigned to Emory University (Atlanta).

"VIP and VIP agonists, nanoparticles, and uses in inflammatory T-cell mediated disease" was invented by Giacomo Waller (Atlanta), Yiwen Li (Atlanta) and Edmund Waller (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "In certain embodiments, this disclosure relates to VIP and VIP agonists, optionally conjugated to nanoparticles, for use in methods of treating inflammatory T cell-mediated diseases or conditions, e.g., treating or preventing GvHD. In certain embodiments, this disclosure relates to methods of pulmonary administration of VIP and VIP agonists, optionally conjugated ...